Israeli intelligence agency Mossad to study China's coronavirus vaccine
Israeli intelligence agency Mossad has acquired China's coronavirus vaccine for conducting a study over it. The animal trials of Israel Institute for Biological Research's (IIBR) coronavirus vaccine "BriLife" has started. "Our final goal is 15 million rations for the residents of the State of Israel and for our close neighbours," said IIBR Director Shmuel Shapira. More than 25,000 doses of the vaccine have been produced by IIBR.